Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease

被引：0
|
作者：
Patoulias, Dimitrios [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Gen Hosp Hippokration, Dept Cardiol 2, Thessaloniki, Greece
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 07期
关键词：
D O I：
10.7326/L23-0069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Dapagliflozin: reduced diabetes incidence in chronic kidney disease?
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (02)
  • [32] Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease
    Calabrese, Vincenzo
    Cernaro, Valeria
    Battaglia, Valeria
    Gembillo, Guido
    Longhitano, Elisa
    Siligato, Rossella
    Sposito, Giovanna
    Ferlazzo, Guido
    Santoro, Domenico
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [33] Effect of Dapagliflozin on Serum Uric Acid Levels in Patients with Advanced Chronic Kidney Disease
    Mori, Daisuke
    Kobayashi, Midori
    Wada, Masafumi
    Tokuchi, Maho
    Misegawa, Soichiro
    Saito, Rina
    Nomi, Hiroki
    Haga, Ryota
    Nagatoya, Katsuyuki
    Yamauchi, Atsushi
    INTERNAL MEDICINE, 2024, 63 (03) : 353 - 357
  • [34] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN DOMINICAN REPUBLIC
    Ordonez, J.
    Dina, E.
    Alvarez, G.
    Rojas, L.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    VALUE IN HEALTH, 2022, 25 (07) : S341 - S341
  • [35] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN COSTA RICA
    Ordonez, J.
    Hernandez, F.
    Rodriguez, G.
    Estrada, J.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    VALUE IN HEALTH, 2022, 25 (07) : S403 - S403
  • [36] Management of chronic kidney disease and its cardiovascular complications: has the dawn of a new era arrived? Comment on 'Dapagliflozin in Patients with Chronic Kidney Disease'
    Liuzzo, Giovanna
    Patrono, Carlo
    EUROPEAN HEART JOURNAL, 2020, 41 (44) : 4231 - 4232
  • [37] Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial
    Bartholdy, Katja Vu
    Johansen, Niklas Dyrby
    Landler, Nino
    Skaarup, Kristoffer Grundtvig
    Jensen, Jesper
    Bressendorff, Iain
    Schou, Morten
    Christensen, Jacob
    Feldt-Rasmussen, Bo
    Vaduganathan, Muthiah
    Solomon, Scott
    Haynes, Richard
    Persson, Frederik
    Rossing, Peter
    Kober, Lars
    Zannad, Faiez
    Hansen, Ditte
    Biering-Sorensen, Tor
    KIDNEY360, 2023, 4 (02): : 143 - 149
  • [38] Rates of Gastrointestinal Hospitalizations in Adults With Chronic Kidney Disease
    Haider, Mahnur
    Baudier, Robin L.
    Batuman, Vecihi
    Srivastava, Anand
    Weir, Matthew
    Anderson, Amanda H.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1062 - S1063
  • [39] EARLY DAPAGLIFLOZIN UTILIZATION FOR CHRONIC KIDNEY DISEASE TREATMENT IN JAPAN
    Sofue, Tadashi
    Takeda, Masayoshi
    Koto, Ryo
    Wright, Jason
    Hong, Lai San
    Nan, Cassandra
    Wittbrodt, Eric
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I514 - I514
  • [40] Cost-Effectiveness of Dapagliflozin for Chronic Kidney Disease in Japan
    Kodera, Satoshi
    Morita, Hiroyuki
    Nishi, Hiroshi
    Takeda, Norifumi
    Ando, Jiro
    Komuro, Issei
    CIRCULATION JOURNAL, 2022, 86 (12) : 2021 - +
12345